Trials / Terminated
TerminatedNCT01415947
V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Edwards Lifesciences · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The V-Chordal System is a new technology for mitral repair. The Valtech V-Chordal system, consists in the ability to adjust (elongate or shorten) the neochordae "off-pump" to achieve an optimal coaptation. The adjustment mechanism allows overcoming the main problem of chordal replacement by enabling accurate sizing of the chords.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | V Chordal | V-Chordal system, consists in the ability to adjust (elongate or shorten) the neochordae "off-pump" . The adjustment mechanism allows overcoming the main problem of chordal replacement by enabling accurate sizing of the chords. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2012-05-01
- Completion
- 2013-03-01
- First posted
- 2011-08-12
- Last updated
- 2014-12-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01415947. Inclusion in this directory is not an endorsement.